Amir Farjam Fazelifar
Overview
Explore the profile of Amir Farjam Fazelifar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasebani Y, Rafati A, Dalouchi S, Bahadori M, Ghoshouni H, Haghjoo M, et al.
Eur J Clin Pharmacol
. 2024 Nov;
81(1):163-172.
PMID: 39570407
Introduction: Inappropriate use of direct oral anticoagulants (DOACs) is common, affecting up to 30% of atrial fibrillation (AF) population receiving treatment for stroke prevention. This study assessed appropriateness of anticoagulation...
2.
Mehdizadeh K, Soveizi M, Askarinejad A, Elahifar A, Masoumi T, Fazelifar A, et al.
BMC Cardiovasc Disord
. 2024 Aug;
24(1):442.
PMID: 39180012
Background: Arrhythmogenic cardiomyopathy (ACM) characterized by progressive myocardial loss and replacement with fibro-fatty tissue is a major cause of sudden cardiac death (SCD). In particular, ACM with predominantly left ventricular...
3.
Kohansal E, Naderi N, Fazelifar A, Maleki M, Kalayinia S
BMC Med Genomics
. 2024 May;
17(1):126.
PMID: 38715010
Background: Long QT syndrome (LQTS) is a cardiac channelopathy characterized by impaired myocardial repolarization that predisposes to life-threatening arrhythmias. This study aimed to elucidate the genetic basis of LQTS in...
4.
Ghaffari Jolfayi A, Kohansal E, Ghasemi S, Naderi N, Hesami M, MozafaryBazargany M, et al.
Sci Rep
. 2024 Mar;
14(1):5313.
PMID: 38438525
The giant protein titin (TTN) is a sarcomeric protein that forms the myofibrillar backbone for the components of the contractile machinery which plays a crucial role in muscle disorders and...
5.
Zandi Z, Eslami M, Kamali F, Teimouri-Jervekani Z, Taherpour M, Mollazadeh R, et al.
Acta Cardiol
. 2023 Nov;
79(3):338-343.
PMID: 38032242
Background: The clinical safety and consequences of upgrade procedures compared with cardiac resynchronisation therapy (CRT) implantation in heart failure remain unclear. The present study aimed to assess clinical and procedural...
6.
Fazelifar A, Talebian F, Ghaffarinejad Z, Habibi M, Pasebani Y, Mazloomi A, et al.
J Electrocardiol
. 2023 Sep;
81:117-122.
PMID: 37688841
Background: Right ventricular hypertrophy can be caused by conditions such as pulmonary stenosis and pulmonary hypertension. ECG is a readily available and affordable test, the aim of this study was...
7.
Fazelifar A, Pourirahim M, Masoumi T, Biglari A, Maleki M, Kalayinia S
J Arrhythm
. 2023 Jun;
39(3):430-453.
PMID: 37324772
Background: Long QT syndrome (LQTS) is a lethal cardiac condition. However, the clinical implementation of genetic testing has now made LQTS eminently treatable. Next-generation sequencing has remarkable potential for both...
8.
Heshmatzad K, Naderi N, Maleki M, Abbasi S, Ghasemi S, Ashrafi N, et al.
J Cell Mol Med
. 2023 May;
27(12):1621-1636.
PMID: 37183561
Cardiovascular diseases (CVDs) constitute one of the significant causes of death worldwide. Different pathological states are linked to CVDs, which despite interventions and treatments, still have poor prognoses. The genetic...
9.
Fazelifar A, Taghavyan N, Moeeni M, Baharestani B, Shahandashti F, Haghjoo M, et al.
J Cardiovasc Electrophysiol
. 2022 Oct;
34(1):209-218.
PMID: 36251326
Introduction: Epicardial pacemakers are known as an alternative for endocardial pacemakers in some cases such as heart block, and complex congenital heart diseases. Considering recent advances and improvement of epicardial...
10.
Parsaee M, Fazelifar A, Ansaripour E, Azarkeyvan A, Ghadrdoost B, Charmizadeh A, et al.
Pulse (Basel)
. 2020 Oct;
8(1-2):15-20.
PMID: 32999874
Background: Iron accumulation leads to increased susceptibility to cardiovascular diseases in thalassemia major (TM) patients. Depressed heart rate variability (HRV) and development of arrhythmia are among the manifestations of subclinical...